MENU
+Compare
EDIT
Stock ticker: NASDAQ
AS OF
Feb 21, 04:59 PM (EDT)
Price
$1.92
Change
-$0.15 (-7.28%)
Capitalization
158.49M

EDIT Editas Medicine Forecast, Technical & Fundamental Analysis

a company which translates genome editing technology into a novel class of human therapeutics

Industry Biotechnology
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for EDIT with price predictions
Feb 20, 2025

Momentum Indicator for EDIT turns positive, indicating new upward trend

EDIT saw its Momentum Indicator move above the 0 level on February 14, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 97 similar instances where the indicator turned positive. In of the 97 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

EDIT moved above its 50-day moving average on February 18, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for EDIT crossed bullishly above the 50-day moving average on February 19, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +13 3-day Advance, the price is estimated to grow further. Considering data from situations where EDIT advanced for three days, in of 245 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for EDIT moved out of overbought territory on February 20, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EDIT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

EDIT broke above its upper Bollinger Band on February 18, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for EDIT entered a downward trend on February 13, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.902) is normal, around the industry mean (12.644). P/E Ratio (0.000) is within average values for comparable stocks, (84.748). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.591). EDIT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (2.553) is also within normal values, averaging (254.739).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EDIT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EDIT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

EDIT is expected to report earnings to fall 56.63% to -32 cents per share on February 26

Editas Medicine EDIT Stock Earnings Reports
Q4'24
Est.
$-0.33
Q3'24
Est.
$-0.75
Q2'24
Missed
by $0.12
Q1'24
Missed
by $0.13
Q4'23
Beat
by $0.36
The last earnings report on November 04 showed earnings per share of -75 cents, meeting the estimate of -75 cents. With 9.47M shares outstanding, the current market capitalization sits at 158.49M.
A.I. Advisor
published General Information

General Information

a company which translates genome editing technology into a novel class of human therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
11 Hurley Street
Phone
+1 617 401-9000
Employees
265
Web
https://www.editasmedicine.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BCLPX8.48N/A
N/A
BlackRock Event Driven Equity Inv C
CAMYX27.67N/A
N/A
Cambiar International Equity Instl
OAYEX19.26N/A
N/A
Oakmark International Small Cap Advisor
SBQUX12.91N/A
N/A
DSS AmericaFirst Large Cap Shr Buyback U
GMAPX28.59N/A
N/A
Goldman Sachs Small Cap Eq Insghts P

EDIT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EDIT has been loosely correlated with NTLA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if EDIT jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDIT
1D Price
Change %
EDIT100%
-35.63%
NTLA - EDIT
62%
Loosely correlated
-0.24%
CRSP - EDIT
60%
Loosely correlated
-4.88%
AXON - EDIT
52%
Loosely correlated
-8.70%
VCYT - EDIT
49%
Loosely correlated
-2.52%
ABCL - EDIT
47%
Loosely correlated
-9.51%
More

Groups containing EDIT

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDIT
1D Price
Change %
EDIT100%
-35.63%
EDIT
(2 stocks)
69%
Closely correlated
-3.81%